Lee, T.; Rawding, P.A.; Bu, J.; Hyun, S.; Rou, W.; Jeon, H.; Kim, S.; Lee, B.; Kubiatowicz, L.J.; Kim, D.;
et al. Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC). Cancers 2022, 14, 2061.
https://doi.org/10.3390/cancers14092061
AMA Style
Lee T, Rawding PA, Bu J, Hyun S, Rou W, Jeon H, Kim S, Lee B, Kubiatowicz LJ, Kim D,
et al. Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC). Cancers. 2022; 14(9):2061.
https://doi.org/10.3390/cancers14092061
Chicago/Turabian Style
Lee, Taehee, Piper A. Rawding, Jiyoon Bu, Sunghee Hyun, Woosun Rou, Hongjae Jeon, Seokhyun Kim, Byungseok Lee, Luke J. Kubiatowicz, Dawon Kim,
and et al. 2022. "Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)" Cancers 14, no. 9: 2061.
https://doi.org/10.3390/cancers14092061
APA Style
Lee, T., Rawding, P. A., Bu, J., Hyun, S., Rou, W., Jeon, H., Kim, S., Lee, B., Kubiatowicz, L. J., Kim, D., Hong, S., & Eun, H.
(2022). Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC). Cancers, 14(9), 2061.
https://doi.org/10.3390/cancers14092061